0001493152-26-006406
SEC filingMobix Labs, Inc. reported a net loss of $10.1 million for Q1 2026, driven by an operating loss of $8.8 million. Revenue for the quarter was $1.9 million with a gross profit of $581 thousand, resulting in a gross margin of 30.6%. The company's operating expenses totaled $9.4 million, dominated by selling, general and administrative expenses of $9.0 million. Cash flow from operations was negative $4.8 million, partially offset by $1.8 million in financing activities, leading to a net decrease in cash of $3.0 million. The balance sheet shows total assets of $32.7 million against total liabilities of $28.1 million, with stockholders' equity of $4.7 million. The company's liquidity position remains constrained with $268 thousand in cash and $25.2 million in current liabilities.
Mobix Labs reported a net loss of $10.1 million for Q1 2026, consistent with the comprehensive loss figure. Revenue for the quarter was $1.9 million with cost of revenue at $1.3 million, yielding gross profit of $581 thousand. Operating expenses totaled $9.4 million, comprising $442 thousand in research and development and $9.0 million in selling, general and administrative expenses. This resulted in an operating loss of $8.8 million. Non-operating items included $1.4 million in interest expense, $960 thousand change in fair value of earnout liability, $323 thousand change in fair value of warrants, and $573 thousand in other non-operating losses. The company reported an income tax benefit of $24 thousand. Basic and diluted net loss per share were both reported as -$0, with weighted-average common shares outstanding of 63.1 million.
Revenue analysis is limited as the filing does not provide segment breakdown, geographic mix, or specific growth drivers beyond the total net revenue figure of $1.9 million. The document does not disclose revenue by product line, customer type, or geographic region. No comparative period revenue figures are provided in the XBRL data or document text, preventing quarter-over-quarter or year-over-year growth rate calculations. The cost of revenue was $1.3 million, representing 68.4% of total revenue.
The company achieved a gross margin of 30.6% ($581 thousand gross profit on $1.9 million revenue). Operating margin was negative 463.2% due to the $8.8 million operating loss. The cost structure shows selling, general and administrative expenses dominated operating expenses at $9.0 million, compared to $442 thousand for research and development. Stock-based compensation of $5.1 million represented a significant non-cash component of expenses. The company's profitability was further impacted by $1.4 million in interest expense and various fair value adjustments totaling $1.3 million.
Operating activities used $4.8 million in cash, despite $10.1 million net loss being adjusted for $5.1 million stock-based compensation, $960 thousand change in fair value of earnout liability, $323 thousand change in fair value of warrants, and other non-cash items. Working capital changes included decreases in accounts receivable ($271 thousand), inventory ($266 thousand), and increases in prepaid expenses ($180 thousand). Financing activities provided $1.8 million through $1.3 million common stock issuance, $55 thousand stock option exercises, and $1.7 million notes payable issuance, partially offset by $1.3 million principal payments. The balance sheet shows $32.7 million total assets including $16.1 million goodwill and $13.1 million intangible assets. Current liabilities of $25.2 million significantly exceed current assets of $2.9 million, with cash of $268 thousand. Total liabilities are $28.1 million against stockholders' equity of $4.7 million.
The filing does not contain management guidance, forward-looking statements, strategic priorities, or specific risk factors beyond the reported financial results. No information is provided about future revenue expectations, expense projections, capital expenditure plans, or strategic initiatives. The document focuses exclusively on historical financial results for the quarter ended December 31, 2025, without discussion of future periods or business outlook.